ASB – Citi rates the stock as Buy
The broker estimates the market is only affording Austal a 3x forward PE for its shipbuilding business, which is a big discount to US peers. Buy and $3.35 target retained.
Read More
MP1 – Morgans rates the stock as Hold
With full details of Megaport’s fourth quarter result now released, Morgans updates forecasts and increases its target price to $16.61 from $15.83.
Read MoreRWC – Ord Minnett rates the stock as Buy
Ord Minnett upgrades its earnings forecasts and increases its target price to $6.20 from $5.90. The broker’s Buy rating is maintained.
Read MoreNCM – Morgans rates the stock as Add
The broker retains its Add rating and reduces its target price to $30.53 from $30.95.
Read MoreCIM – Credit Suisse rates the stock as Outperform
Credit Suisse upgrades to Outperform from Neutral and raises the target to $23.60 from $ 21.90.
Read MoreS32 – Morgans rates the stock as Hold
The broker maintains its Hold rating and lowers its target price to $3.15 from $3.25.
Read MoreBPT – Morgans rates the stock as Add
The broker retains its add rating and lowers its target to $1.77 from $1.86.
Read MoreDRR – Credit Suisse rates the stock as Outperform
Outperform rating and $5 target maintained.
Read MoreOSH – UBS rates the stock as Buy
Buy rating and $4.60 target unchanged.
Read MoreANZ – Morgans rates the stock as Add
Morgans retains its Add rating and $34.50 target.
Read MoreIAG – UBS rates the stock as Buy
Buy rating maintained. Target is reduced to $5.80 from $6.00.
Read MoreBHP – Morgans rates the stock as Hold
Morgans retains its Hold rating and lowers its target price to $44.70 from $45.80.
Read MoreANZ – Citi rates the stock as Neutral
Citi retains its Neutral rating and $29.50 target price.
Read MoreEDV – Credit Suisse rates the stock as Underperform
Credit Suisse initiates coverage on Endeavour Group with an Underperform rating and sets a target price of $5.86.
Read MoreDTL – Morgans rates the stock as Hold
Morgans lifts its target price to $5.90 from $5.75 and maintains its Hold rating.
Read MoreAWC – Macquarie rates the stock as Underperform
The broker expects continued margin suppression as cost pressures remain evident in the second half. Underperform maintained. Target is reduced to $1.30 from $1.50.
Read MoreRIO – Morgans rates the stock as Hold
The broker maintains its Hold rating and lowers its target price to $120 from $121.
Read MoreARB – Credit Suisse rates the stock as Neutral
Neutral rating is retained and the target price increases to $44.40 from $37.00
Read MoreWPL – UBS rates the stock as Buy
The Buy rating is retained and the target price decreases to $26.10 from $26.20.
Read MoreSYD – Morgans rates the stock as Hold
Morgans’ Hold rating and $8.25 target are maintained.
Read MoreARB – Macquarie rates the stock as Neutral
Neutral maintained. Target rises to $40.10 from $36.10.
Read MoreSFR – Credit Suisse rates the stock as Outperform
Outperform rating retained. Target is $8.55.
Read MoreGDG – Morgans rates the stock as Add
The broker lifts FY21-FY23 EPS forecasts by around 2%-13% on an increase to in sales assumptions and the target price rises to $1.16 from $1.03.
Read MoreNWH – Macquarie rates the stock as Outperform
The analyst maintains the Outperform rating and $2.10 target price.
Read MoreIPL – UBS rates the stock as Buy
The analyst raises the target price to $2.91 from $2.88 and maintains the Buy rating.
Read MoreICQ – Morgans rates the stock as Hold
Morgans maintains a Hold rating. The target moves to $0.50 from $0.38, factoring-in a 75% chance of the recent Carsome bid becoming final.
Read MoreSUN – Macquarie rates the stock as Outperform
The broker maintains an Outperform recommendation for Suncorp Group. The target price slips to $12.80 from $13.20.
Read MoreWOW – Citi rates the stock as Neutral
Citi resumes coverage of Woolworths post the de-merger of Endeavour Group ((EDV)) with a Neutral rating and $37.60 target.
Read MoreFPH – UBS rates the stock as Sell
UBS retains a Sell rating, believing the stock is overvalued and there will be negative earnings momentum as covid-19 hospitalisation rates fade. Target is NZ$22.65.
Read MoreCBA – Macquarie rates the stock as Underperform
Rating is downgraded to Underperform from Neutral, following a strong rally in the share price. Target is raised to $88.50 from $86.00.
Read MoreHUB – Credit Suisse rates the stock as Outperform
Outperform rating and $31.50 target maintained.
Read MoreVEA – UBS rates the stock as Buy
Buy retained. Target rises to $2.45 from $2.35.
Read MoreCIP – Morgans rates the stock as Hold
Morgans increases the target price to $3.71 from $3.55 and retains the Hold rating.
Read MoreQBE – Credit Suisse rates the stock as Outperform
The Outperform rating and $13.30 target are retained.
Read MoreRFF – UBS rates the stock as Neutral
Neutral rating remains with the target price increasing to $2.65 from $2.43.
Read MoreAQR – Morgans rates the stock as Add
The analyst’s Add rating and $4.15 target are retained.
Read MoreSFR – Macquarie rates the stock as Outperform
The Outperform rating and $10 target are unchanged.
Read MoreORG – Credit Suisse rates the stock as Neutral
Target is raised to $4.50 from $4.20. Neutral maintained.
Read MoreBGA – Morgans rates the stock as Add
The target price falls to $6.35 from $6.80. The Add rating is unchanged.
Read MoreAGL – Credit Suisse rates the stock as Underperform
The target is reduced to $6.70 from $6.80 and an Underperform rating is maintained, with the broker anticipating further downgrades to consensus FY22 and FY23 earnings forecasts.
Read More